掌閲科技(603533.SH):已經將相關的AI閲讀思路、技術深度融合在公司閲讀主APP“掌閲”之中
格隆匯7月19日丨掌閲科技(603533.SH)在投資者互動平台表示,“閲愛聊”是公司數字閲讀產品與AI大模型相結合的MVP(最小化可行產品)。該產品的成功開發,讓公司快速驗證了AI閲讀的產品原型,該產品不再單獨升級迭代,公司已經將相關的AI閲讀思路、技術深度融合在公司閲讀主APP“掌閲”之中。目前與AI大模型深度融合的“掌閲”APP正在小範圍用户測試之中,請您關注公司AI閲讀官方公眾號“掌閲AI閲”,按照裏面的指引申請加入內測,以獲取高品質的智能閲讀體驗。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.